Ewing’s sarcoma origin: from duel to duality

References

• Bennicelli JL, Barr FG. Genetics and the biologic basis of sarcomas. Curr. Opin. Oncol.11(4), 267–274 (1999).
   PubMed Web of Science ®Google Scholar
• Bennicelli JL, Barr FG. Chromosomal translocations and sarcomas. Curr. Opin. Oncol.14(4), 412–419 (2002).
   PubMed Web of Science ®Google Scholar
• Busam KJ, Fletcher CD. The clinical role of molecular genetics in soft tissue tumor pathology. Cancer Metastasis Rev.16(1–2), 207–227 (1997).
   PubMed Web of Science ®Google Scholar
• Dockhorn-Dworniczak B, Schafer KL, Blasius S et al. Assessment of molecular genetic detection of chromosome translocations in the differential diagnosis of pediatric sarcomas. Klin. Padiatr.209(4), 156–641 (1997).
   PubMed Web of Science ®Google Scholar
• Helman LJ, Meltzer P. Mechanisms of sarcoma development. Nat. Rev. Cancer3(9), 685–694 (2003).
   PubMed Web of Science ®Google Scholar
• Shipley J, Crew J, Gusterson B. The molecular biology of soft tissue sarcomas. Eur. J. Cancer29A(14), 2054–2058 (1993).
   PubMed Web of Science ®Google Scholar
• Keller C, Arenkiel BR, Coffin CM, El-Bardeesy N, DePinho RA, Capecchi MR. Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function. Genes Dev.18(21), 2614–2626 (2004).
   PubMed Web of Science ®Google Scholar
• Haldar M, Hancock JD, Coffin CM, Lessnick SL, Capecchi MR. A conditional mouse model of synovial sarcoma: insights into a myogenic origin. Cancer Cell.11(4), 375–388 (2007).
   PubMed Web of Science ®Google Scholar
• Perez-Losada J, Pintado B, Gutierrez-Adan A et al. The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice. Oncogene19(20), 2413–2422 (2000).
   PubMed Web of Science ®Google Scholar
• Delattre O, Zucman J, Plougastel B et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature359(6391), 162–165 (1992).
   PubMed Web of Science ®Google Scholar
• Arvand A, Bastians H, Welford SM, Thompson AD, Ruderman JV, Denny CT. EWS/FLI1 up regulates mE2-C, a cyclin-selective ubiquitin conjugating enzyme involved in cyclin B destruction. Oncogene17(16), 2039–2045 (1998).
   PubMed Web of Science ®Google Scholar
• May WA, Arvand A, Thompson AD, Braun BS, Wright M, Denny CT. EWS/FLI1-induced manic fringe renders NIH 3T3 cells tumorigenic. Nat. Genet.17(4), 495–497 (1997).
   PubMed Web of Science ®Google Scholar
• Thompson AD, Braun BS, Arvand A, et al. EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing’s sarcoma EWS/FLI1 fusion gene. Oncogene13(12), 2649–2658 (1996).
   PubMed Web of Science ®Google Scholar
• Riggi N, Cironi L, Suva ML, Stamenkovic I. Sarcomas: genetics, signalling, and cellular origins. Part 1: the fellowship of TET. J. Pathol.213(1), 4–20 (2007).
   PubMed Web of Science ®Google Scholar
• Kovar H, Aryee DN, Jug G, et al. EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro . Cell Growth Differ.7(4), 429–437 (1996).
   PubMedGoogle Scholar
• Ushigome S, Machinami R, Sorensen PH. Ewing sarcoma/primitive neuroectodermal tumor. In: WHO Classification of Tumors, Pathology and Genetics, Tumors of Soft Tissue and Bone. Fletcher CDM, Unni KK, Mertens F (Eds). 298–300 (2003).
   Google Scholar
• May WA, Gishizky ML, Lessnick SL et al. Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc. Natl Acad. Sci. USA90(12), 5752–5756 (1993).
   PubMed Web of Science ®Google Scholar
• Thompson AD, Teitell MA, Arvand A, Denny CT. Divergent Ewing’s sarcoma EWS/ETS fusions confer a common tumorigenic phenotype on NIH3T3 cells. Oncogene18(40), 5506–5513 (1999).
   PubMed Web of Science ®Google Scholar
• Deneen B, Denny CT. Loss of p16 pathways stabilizes EWS/FLI1 expression and complements EWS/FLI1 mediated transformation. Oncogene20(46), 6731–6741 (2001).
   PubMed Web of Science ®Google Scholar
• Lessnick SL, Dacwag CS, Golub TR. The Ewing’s sarcoma oncoprotein EWS/FLI induces a p53-dependent growth arrest in primary human fibroblasts. Cancer Cell.1(4), 393–401 (2002).
   PubMed Web of Science ®Google Scholar
• Castillero-Trejo Y, Eliazer S, Xiang L, Richardson JA, Ilaria RL Jr. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells results in EWS/FLI-1-dependent, ewing sarcoma-like tumors. Cancer Res.65(19), 8698–8705 (2005).
   PubMed Web of Science ®Google Scholar
• Riggi N, Cironi L, Provero P, et al. Development of Ewing’s sarcoma from primary bone marrow-derived mesenchymal progenitor cells. Cancer Res.65(24), 11459–11468 (2005).
   PubMed Web of Science ®Google Scholar
• Miyagawa Y, Okita H, Nakaijima H, et al. Inducible expression of chimeric EWS/ETS proteins confers Ewing’s family tumor-like phenotypes to human mesenchymal progenitor cells. Mol. Cell. Biol.28(7), 2125–2137 (2008).
   PubMed Web of Science ®Google Scholar
• Riggi N, Suva ML, Suva D, et al. EWS–FLI-1 expression triggers a Ewing’s sarcoma initiation program in primary human mesenchymal stem cells. Cancer Res.68(7), 2176–2185 (2008).
   PubMed Web of Science ®Google Scholar
• Staege MS, Hutter C, Neumann I, et al. DNA microarrays reveal relationship of Ewing family tumors to both endothelial and fetal neural crest-derived cells and define novel targets. Cancer Res.64(22), 8213–8221 (2004).
   PubMed Web of Science ®Google Scholar
• Kauer M, Ban J, Kofler R et al. A molecular function map of Ewing’s sarcoma. PLoS ONE4(4), e5415 (2009).
   PubMed Web of Science ®Google Scholar
• Tirode F, Laud-Duval K, Prieur A, Delorme B, Charbord P, Delattre O. Mesenchymal stem cell features of Ewing tumors. Cancer Cell.11(5), 421–429 (2007).
   PubMed Web of Science ®Google Scholar
• Suva ML, Riggi N, Stehle JC, et al. Identification of cancer stem cells in Ewing’s sarcoma. Cancer Res.69(5), 1776–1781 (2009).
   PubMed Web of Science ®Google Scholar
• Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science276(5309), 71–74 (1997).
   PubMed Web of Science ®Google Scholar
• Ogawa M, LaRue AC, Drake CJ. Hematopoietic origin of fibroblasts/myofibroblasts: its pathophysiologic implications. Blood108(9), 2893–2896 (2006).
   PubMed Web of Science ®Google Scholar
• Takashima Y, Era T, Nakao K, et al. Neuroepithelial cells supply an initial transient wave of MSC differentiation. Cell129(7), 1377–1388 (2007).
   PubMed Web of Science ®Google Scholar
• Lee G, Kim H, Elkabetz Y et al. Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells. Nat. Biotechnol.25(12), 1468–1475 (2007).
   PubMed Web of Science ®Google Scholar
• Charytonowicz E. Alveolar rhabdomyosarcoma: is the cell of origin a mesenchymal stem cell?. Cancer Lett.279(2), 126–136 (2008).
   PubMed Web of Science ®Google Scholar